|
Barreda-Bonis A.C., de Bergua Domingo J.M., Galán-Gómez E., Guillén-Navarro E., Leiva-Gea I., Riaño-Galán I. Expert consensus for the management of patients with achondroplasia in treatment with vosoritide. Anales de Pediatria. December 2024. 101:401-410. 10.1016/j.anpedi.2024.09.005
AÑO: 2024; IF: 2.1
|
|
Galan Carrillo I, Galbis Martinez L, Martinez V, Roca Merono S, Ramos F, Gonzalez Rodriguez JD, Pinero Fernandez J, Guillen Navarro E. Multidisciplinary management improves the genetic diagnosis of hereditary kidney diseases in the next generation sequencing (NGS) era. Nefrologia (Engl Ed). 2024 Jan-Feb;44(1):69-76. doi: 10.1016/j.nefroe.2024.02.002. Epub 2024 Feb 27. PubMed PMID: 38418364.
AÑO: 2024
|
|
Galán Carrillo I., Galbis Martínez L., Martínez V., Roca Meroño S., Ramos F., González Rodríguez J.D., Piñero Fernández J., Guillén Navarro E. Multidisciplinary management improves the genetic diagnosis of hereditary kidney diseases in the next generation sequencing (NGS) era. Nefrologia. 1 January 2024. 44:69-76. 10.1016/j.nefro.2022.11.003
AÑO: 2024; IF: 2.6
|
|
Sanchez-Villalobos M, Campos Banos E, Juan Fita MJ, Egea Mellado JM, Gonzalez Gallego I, Beltran Videla A, Berenguer Piqueras M, Bermudez Cortes M, Moraleda Jimenez JM, Guillen Navarro E, Salido Fierrez E, Perez-Oliva AB. A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain). Int J Neonatal Screen. 2023 Oct 10;9(4):55. doi: 10.3390/ijns9040055. PubMed PMID: 37873846; PubMed Central PMCID: PMC10594431.
AÑO: 2023; IF: 3.5
|
|
Carcavilla A, Cambra A, Santome JL, Seidel V, Cruz J, Alonso M, Pozo J, Valenzuela I, Guillen-Navarro E, Santos-Simarro F, Gonzalez-Casado I, Rodriguez A, Medrano C, Lopez-Siguero JP, Ezquieta B. Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment. J Clin Med. 2023 Jul 29;12(15):5003. doi: 10.3390/jcm12155003. PubMed PMID: 37568403; PubMed Central PMCID: PMC10420167.
AÑO: 2023; IF: 3.0
|